Status:
COMPLETED
Serological Testing for COVID-19 (SARS-CoV-2) in ESKD
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
SARS-CoV 2
End Stage Renal Failure on Dialysis
Eligibility:
All Genders
18+ years
Brief Summary
Starting in late 2019, the world is facing a pandemic with the SARS-CoV-2 virus. Patients with end-stage kidney disease and on treatment with renal replacement therapy are high risk patients, as they ...
Detailed Description
In late 2019, a cluster of patients with unexplained pneumonia was linked to a novel beta-coronavirus, now known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 1. The world health org...
Eligibility Criteria
Inclusion
- Patients with end-stage kidney disease (ESKD) receiving renal replacement therapy
- Age 18 years or older
- Treated at University Hospitals Leuven, or Jessa Ziekenhuis Hasselt
- Providing informed consent
Exclusion
- Refusal to provide informed consent
- Transfer to another dialysis unit
Key Trial Info
Start Date :
April 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 12 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04378686
Start Date
April 23 2020
End Date
December 12 2022
Last Update
July 3 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Jessa Ziekenhuis
Hasselt, Limburg, Belgium, 3500
2
Sint Trudo
Sint-Truiden, Limburg, Belgium, 3800
3
University Hospitals Leuven
Leuven, Belgium, 3000